Key Developments: NuVasive Inc (NUVA.OQ)

NUVA.OQ on NASDAQ Stock Exchange Global Select Market

35.53USD
22 Aug 2014
Price Change (% chg)

$-0.16 (-0.45%)
Prev Close
$35.69
Open
$35.54
Day's High
$35.82
Day's Low
$35.38
Volume
43,946
Avg. Vol
120,076
52-wk High
$39.89
52-wk Low
$23.17

Search Stocks

Latest Key Developments (Source: Significant Developments)

NuVasive Inc raises FY 2014 guidance
Tuesday, 29 Jul 2014 04:30pm EDT 

NuVasive Inc:Updates projections to FY 2014 guidance.Expects FY 2014 revenue of about $745 million increased from about $725 million previously.Expects FY 2014 GAAP Loss per Share of about ($0.38); compared to Loss per Share of about ($0.27) previously.Expects FY 2014 Non-GAAP EPS of about $1.11; increased from about $1.06 previously.FY 2014 revenue of $730 mln and EPS of $1.09 - Thomson Reuters I/B/E/S.  Full Article

NuVasive Inc reaffirms FY 2014 guidance - Conference Call
Wednesday, 11 Jun 2014 09:40am EDT 

NuVasive Inc:Expects FY 2014 6pct revenue growth figure, that would put at $725 million.From EPS perspective it will land at roughly $1.06 for FY 2014.FY 2014 EPS of $1.09 - Thomson Reuters I/B/E/S.  Full Article

NuVasive announces management changes
Tuesday, 29 Apr 2014 04:39pm EDT 

NuVasive Inc:Says Michael Lambert intends to retire from his role as Chief Financial Officer later this year.Quentin Blackford, current Executive Vice President of Finance, Accounting and Investor Relations, will succeed Michael Lambert effective August 1.  Full Article

NuVasive Inc reaffirms FY 2014 guidance
Tuesday, 29 Apr 2014 04:30pm EDT 

NuVasive Inc:Expects FY 2014 revenue of about $725 mln; unchanged from prior guidance.Expects FY 2014 GAAP loss per share of about ($0.27); compared to earnings per share of $0.11 previously.Expects FY 2014 non-GAAP EPS of about $1.06; unchanged from prior guidance.FY 2014 revenue of $728 mln and EPS of $1.08 - Thomson Reuters I/B/E/S.  Full Article

NuVasive Inc gives FY 2014 guidance; EPS guidance below analysts' estimates
Monday, 3 Mar 2014 04:30pm EST 

NuVasive Inc:Expects FY 2014 revenue of about $725 million.Expects FY 2014 GAAP EPS of about $0.11.Expects FY 2014 non-GAAP EPS of about $1.06.FY 2014 revenue of $719 million and EPS of $1.26 - Thomson Reuters I/B/E/S.  Full Article

NuVasive Inc raises FY 2013 revenue guidance
Wednesday, 15 Jan 2014 08:00am EST 

NuVasive Inc:Sees FY 2013 revenue to be about $683 million.Says the unaudited revenue results compare to previously issued guidance of about $670 million in revenue for FY 2013.FY 2013 revenues of $671 million - Thomson Reuters I/B/E/S Estimates.  Full Article

NuVasive Inc Raises FY 2013 Guidance
Tuesday, 29 Oct 2013 04:30pm EDT 

NuVasive Inc announced that for fiscal 2013, it expects revenue of approximately $670 million, up from prior guidance of $655 million, GAAP earnings per share of approximately $0.07, up from prior guidance of a loss per share of ($0.09) and Non-GAAP EPS of approximately $1.14, up from prior guidance of $1.00. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $657 million and EPS of $1.00 for fiscal 2013.  Full Article

Glancy Binkow & Goldberg Announces Lead Plaintiff Deadline In Class Action Lawsuit Against NuVasive Inc
Friday, 18 Oct 2013 10:24pm EDT 

Glancy Binkow & Goldberg LLP announced that all purchasers of the securities of NuVasive, Inc. between October 22, 2008 and July 30, 2013, inclusive (the Class Period) have until October 28, 2013, to file a motion to be appointed as lead plaintiff in the shareholder lawsuit filed in the United States District Court for the Southern District of California. The Complaint alleges that the Company issued false and/or misleading statements and failed to disclose that the Company improperly submitted false claims to Medicare and Medicaid in violation of federal and state laws and regulations; and as a result of the foregoing, the Company's statements were materially false and misleading at all relevant times.  Full Article

Brower Piven, A Professional Corporation announces Commencement Of Class Action Lawsuit NuVasive Inc
Tuesday, 1 Oct 2013 05:36pm EDT 

Brower Piven, A Professional Corporation announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of California on behalf of purchasers of NuVasive Inc securities during the period between October 22, 2008 and July 30, 2013, inclusive (the "Class Period").  Full Article

Law Offices Of Howard G. Smith Announces Class Action Lawsuit Against NuVasive Inc
Saturday, 21 Sep 2013 05:32pm EDT 

Law Offices of Howard G. Smith announced that a class action lawsuit has been filed in the United States District Court for the Southern District of California on behalf of a class (the Class) comprising all purchasers of the securities of NuVasive Inc between October 22, 2008 and July 30, 2013, inclusive (the Class Period). The Complaint alleges that defendants issued false and/or misleading statements and failed to disclose material adverse facts about NuVasive`s business, operations and prospects. Specifically: (1) the Company improperly submitted false claims to Medicare and Medicaid in violation of federal and state laws and regulations; and (2) as a result of the foregoing, the Company's statements were materially false and misleading at all relevant times. On July 30, 2013, the Company disclosed that it had received a federal administrative subpoena from the Office of the Inspector General of the U.S. Department of Health and Human Services in connection with an investigation into "possible false or otherwise improper claims submitted to Medicare and Medicaid." As a result of this news, NuVasive securities declined $3.28 per share, or over 12%, to close at $22.84 per share on July 31, 2013.  Full Article

Search Stocks